Uptake of evidence by physicians: De-adoption of erythropoiesis-stimulating agents after the TREAT trial

BACKGROUND: Variation in de-adoption of ineffective or unsafe treatments is not well-understood. We examined de-adoption of erythropoiesis-stimulating agents (ESA) in anemia treatment among patients with chronic kidney disease (CKD) following new clinical evidence of harm and ineffectiveness (the TR...

Descripción completa

Detalles Bibliográficos
Autores principales: Vu, Khoa, Zhou, Jiani, Everhart, Alexander, Desai, Nihar, Herrin, Jeph, Jena, Anupam B., Ross, Joseph S., Shah, Nilay D., Karaca-Mandic, Pinar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379779/
https://www.ncbi.nlm.nih.gov/pubmed/34419007
http://dx.doi.org/10.1186/s12882-021-02491-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379779/
https://www.ncbi.nlm.nih.gov/pubmed/34419007
http://dx.doi.org/10.1186/s12882-021-02491-y

Ejemplares similares